The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Berikkhanov Z.G.

Sechenov First Moscow State Medical University

Nikolaev A.M.

Sechenov First Moscow State Medical University

Seryogina V.Yu.

Sechenov First Moscow State Medical University

Treatment of chronic obstructive pulmonary disease and emphysema

Authors:

Berikkhanov Z.G., Nikolaev A.M., Seryogina V.Yu.

More about the authors

Journal: Pirogov Russian Journal of Surgery. 2023;(9): 79‑85

DOI: 10.17116/hirurgia202309179

Views: 2319

Downloaded: 46

Download PDF (RU)
Contact the author
Table of contents

TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND EMPHYSEMA
TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND EMPHYSEMA

To cite this article:

Berikkhanov ZG, Nikolaev AM, Seryogina VYu. Treatment of chronic obstructive pulmonary disease and emphysema. Pirogov Russian Journal of Surgery. 2023;(9):79‑85. (In Russ.)
https://doi.org/10.17116/hirurgia202309179

Подписка 2025-2 (Pirogov Russian Journal of Surgery)
МСФ на ЯМ
Close metadata
Recommended articles:
Thoracoscopic thymectomy for myasthenia gravis and non-invasive thymoma after COVID-19 pneumonia. Piro­gov Russian Journal of Surgery. 2024;(8):26-33
Clinical and epidemiological characteristics of bronchial asthma and chro­nic obstructive pulmonary disease inci­dence in Russia before and during the COVID-19 epidemy. Russian Journal of Preventive Medi­cine. 2024;(6):42-48
Addi­tional criteria to differentiate the chro­nic obstructive pulmonary disease exacerbation and acute deco­mpensated chro­nic heart failure. Russian Journal of Preventive Medi­cine. 2024;(11):102-107
Chro­nic obstructive pulmonary disease (COPD 2024). Clinical guidelines (short version). Journal of Respiratory Medi­cine. 2025;(2):5-16
Toba­cco smoking as a factor in the deve­lopment of COPD and pulmonary tube­rculosis. Journal of Respiratory Medi­cine. 2025;(2):45-50
Rese­rves for redu­cing exacerbations in patients with chro­nic obstructive pulmonary disease at a large indu­strial ente­rprise. Journal of Respiratory Medi­cine. 2025;(2):66-70
Prognostic factors for progression and risk chro­nic obstructive pulmonary disease adve­rse outcomes. Journal of Respiratory Medi­cine. 2025;(2):71-78

We summarized the available data on therapeutic, surgical and endoscopic treatment of chronic obstructive pulmonary disease and emphysema that may be used like a bridge to lung transplantation. Treatment of chronic obstructive pulmonary disease and emphysema is expensive. Certain limitations in lung transplantation make to create new methods of treatment of severe emphysema. However, one should be ready for possible complications and carefully select patients for certain treatment to avoid false negative results. Reducing costs or developing cheaper treatments is important for the future and availability of care. The risks and complications associated with surgical treatment of emphysema can make endoscopic surgery preferable for these patients, and this undoubtedly requires further research.

Keywords:

chronic obstructive pulmonary disease
pulmonary emphysema
lung volume reduction
lung transplantation

Authors:

Berikkhanov Z.G.

Sechenov First Moscow State Medical University

Nikolaev A.M.

Sechenov First Moscow State Medical University

Seryogina V.Yu.

Sechenov First Moscow State Medical University

Received:

27.01.2023

Accepted:

02.03.2023

List of references:

  1. Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. 2017. Accessed February 1, 2023. https://goldcopd.org
  2. Halpin DMG, Celli BR, Criner GJ, Frith P, López Varela MV, Salvi S, Vogelmeier CF, Chen R, Mortimer K, Montes de Oca M, Aisanov Z, Obaseki D, Decker R, Agusti A. The GOLD Summit on chronic obstructive pulmonary disease in low- and middle-income countries. The International Journal Tuberculosis and Lung Disease. 2019;23(11):1131-1141. https://doi.org/10.5588/ijtld.19.0397
  3. Foray N, Stone T, White P. Alpha1-antitrypsin Disease, Treatment and Role for Lung Volume Reduction Surgery. Thoracic Surgery Clinics. 2021;31(2):139-160.  https://doi.org/10.1016/j.thorsurg.2021.02.002
  4. Calverley PMA, Anderson JA, Brook RD, Crim C, Gallot N, Kilbride S, Martinez FJ, Yates J, Newby DE, Vestbo J, Wise R, Celli BR; SUMMIT (Study to Understand Mortality and Morbidity) Investigators. Fluticasone Furoate, Vilanterol, and Lung Function Decline in Patients with Moderate Chronic Obstructive Pulmonary Disease and Heightened Cardiovascular Risk. American Journal of Respiratory and Critical Care Medicine. 2018;197(1):47-55.  https://doi.org/10.1164/rccm.201610-2086OC
  5. Storre JH, Callegari J, Magnet FS, Schwarz SB, Duiverman ML, Wijkstra PJ, Windisch W. Home noninvasive ventilatory support for patients with chronic obstructive pulmonary disease: patient selection and perspectives. International Journal of Chronic Obstructive Pulmonary Disease. 2018;13:753-760. 
  6. Press VG, Cifu AS, White SR. Screening for Chronic Obstructive Pulmonary Disease. JAMA. 2017;318(17):1702-1703.
  7. Dummer J, Dobler CC, Holmes M, Chambers D, Yang IA, Parkin L, Smith S, Wark P, Dev A, Hodge S, Dabscheck E, Gooi J, Samuel S, Knowles S, Holland AE. Diagnosis and treatment of lung disease associated with alpha one-antitrypsin deficiency: A position statement from the Thoracic Society of Australia and New Zealand. Respirology. 2020;25(3):321-335.  https://doi.org/10.1111/resp.13774
  8. Janssen R, Piscaer I, Franssen FME, Wouters EFM. Emphysema: looking beyond alpha-1 antitrypsin deficiency. Expert Review of Respiratory Medicine. 2019;13(4):381-397.  https://doi.org/10.1080/17476348.2019.1580575
  9. Kyung SY, Kim YJ, Son ES, Jeong SH, Park JW. The Phosphodiesterase 4 Inhibitor Roflumilast Protects against Cigarette Smoke Extract-Induced Mitophagy-Dependent Cell Death in Epithelial Cells. Tuberculosis and Respiratory Diseases. 2018;81(2):138-147.  https://doi.org/10.4046/trd.2017.0115
  10. Polverino F, Wu TD, Rojas-Quintero J, Wang X, Mayo J, Tomchaney M, Tram J, Packard S, Zhang D, Cleveland KH, Cordoba-Lanus E, Owen CA, Fawzy A, Kinney GL, Hersh CP, Hansel NN, Doubleday K, Sauler M, Tesfaigzi Y, Ledford JG, Casanova C, Zmijewski J, Konhilas J, Langlais PR, Schnellmann R, Rahman I, McCormack M, Celli B. Metformin: Experimental and Clinical Evidence for a Potential Role in Emphysema Treatment. American Journal of Respiratory and Critical Care Medicine. 2021;204(6):651-666.  https://doi.org/10.1164/rccm.202012-4510OC
  11. Ergan B, Nava S. Long-Term Oxygen Therapy in COPD Patients Who Do Not Meet the Actual Recommendations. COPD. 2017;14(3):351-366.  https://doi.org/10.1080/15412555.2017.1319918
  12. Brat K, Plutinsky M, Hejduk K, Svoboda M, Popelkova P, Zatloukal J, Volakova E, Fecaninova M, Heribanova L, Koblizek V. Respiratory parameters predict poor outcome in COPD patients, category GOLD 2017 B. International Journal of Chronic Obstructive Pulmonary Disease. 2018;13:1037-1052. https://doi.org/10.2147/COPD.S147262
  13. Marwah V, Dhar R, Choudhary R, Elliot M. Domiciliary noninvasive ventilation for chronic respiratory diseases. Medical Journal Armed Forces India. 2022;78(4):380-386.  https://doi.org/10.1016/j.mjafi.2022.09.006
  14. Macrea M, Coleman JM 3rd. The Role of Long-Term Noninvasive Ventilation in Chronic Stable Hypercapnic Chronic Obstructive Pulmonary Disease. Medical Clinics of North America. 2022;106(6):961-969.  https://doi.org/10.1016/j.mcna.2022.07.004
  15. Breen A, Avsar P, Moore Z, O’Connor T, Nugent L, Patton D. What is the impact of home non-invasive ventilation on the health-related quality of life of patients with chronic obstructive pulmonary disease? A systematic review. Quality of Life Research. 2023;32(7):1843-1857. https://doi.org/10.1007/s11136-022-03310-z
  16. Slebos DJ, Klooster K, Koegelenberg CF, Theron J, Styen D, Valipour A, Mayse M, Bolliger CT. Targeted lung denervation for moderate to severe COPD: a pilot study. Thorax. 2015;70(5):411-49.  https://doi.org/10.1136/thoraxjnl-2014-206146
  17. Pison C, Shah PL, Slebos DJ, Ninane V, Janssens W, Perez T, Kessler R, Deslee G, Garner JL, Hartman JE, Degano B, Mayr A, Mayse M, Peterson AD, Valipour A. Safety of denervation following targeted lung denervation therapy for COPD: AIRFLOW-1 3-year outcomes. Respiratory Research. 2021;22(1):62.  https://doi.org/10.1186/s12931-021-01664-5
  18. Tschopp JM, Rami-Porta R, Noppen M, Astoul P. Management of spontaneous pneumothorax: state of the art. European Respiratory Journal. 2006;28(3):637-650.  https://doi.org/10.1183/09031936.06.00014206
  19. Mishina T, Watanabe A, Miyajima M, Nakazawa J. Relationship between onset of spontaneous pneumothorax and weather conditions. European Journal of Cardio-Thoracic Surgery. 2017;52(3):529-533.  https://doi.org/10.1093/ejcts/ezx128
  20. Park S, Jang HJ, Song JH, Bae SY, Kim H, Nam SH, Lee JH. Do Blebs or Bullae on High-Resolution Computed Tomography Predict Ipsilateral Recurrence in Young Patients at the First Episode of Primary Spontaneous Pneumothorax? Korean Journal of Thoracic and Cardiovascular Surgery. 2019;52(2):91-99.  https://doi.org/10.5090/kjtcs.2019.52.2.91
  21. Saha BK, Chong WH, Hu K, Saha S, Bonnier A, Chenna P. Pressure-dependent persistent air leak in a patient with secondary spontaneous pneumothorax. The American Journal of the Medical Sciences. 2022;364(6):782-788.  https://doi.org/10.1016/j.amjms.2022.06.013
  22. Joshi V, Kirmani B, Zacharias J. Thoracotomy versus VATS: is there an optimal approach to treating pneumothorax? Annals of the Royal College of Surgeons of England. 2013;95(1):61-64.  https://doi.org/10.1308/003588413X13511609956138
  23. Li X, Wang X, Zhang H, Cheng H, Cao Q. Unilateral single-port thoracoscopic surgery for bilateral pneumothorax or pulmonary bullae. Journal of Cardio-Thoracic Surgery. 2019;14(1):71.  https://doi.org/10.1186/s13019-019-0894-y
  24. Pompeo E, Tacconi F, Frasca L, Mineo TC. Awake thoracoscopic bullaplasty. European Journal of Cardio-Thoracic Surgery. 2011;39(6):1012-1017. https://doi.org/10.1016/j.ejcts.2010.09.029
  25. He J, Liu J, Zhu C, Dai T, Cai K, Zhang Z, Cheng C, Qiao K, Liu X, Wang G, Xu S, Yang R, Fan J, Li H, Jin J, Dong Q, Liang L, Ding J, He K, Liu Y, Ye J, Feng S, Jiang Y, Huang H, Zhang H, Liu Z, Feng X, Xia Z, Ma M, Duan Z, Huang T, Li Y, Shen Q, Tan W, Ma H, Sun Y, Chen C, Cui F, Wang W, Li J, Hao Z, Liu H, Liang W, Zou X, Liang H, Yang H, Li Y, Jiang S, Ng CSH, González-Rivas D, Pompeo E, Flores RM, Shargall Y, Ismail M, Bedetti B, Elkhouly AG, Ang K. Expert consensus on spontaneous ventilation video-assisted thoracoscopic surgery in primary spontaneous pneumothorax (Guangzhou). Annals of Translation Medicine. 2019;7(20):518.  https://doi.org/10.21037/atm.2019.10.08
  26. Shah PL, Herth FJ, van Geffen WH, Deslee G, Slebos DJ. Lung volume reduction for emphysema. The Lancet Respiratory Medicine. 2017;5(2):147-156.  https://doi.org/10.1016/S2213-2600(16)30221-1
  27. Duffy S, Marchetti N, Criner GJ. Surgical Therapies for Chronic Obstructive Pulmonary Disease. Clinics in Chest Medicine. 2020;41(3):559-566.  https://doi.org/10.1016/j.ccm.2020.06.011
  28. Van Agteren JE, Carson KV, Tiong LU, Smith BJ. Lung volume reduction surgery for diffuse emphysema. Cochrane Database and Systematic Reviews. 2016;10(10):CD001001. https://doi.org/10.1002/14651858.CD001001.pub3
  29. Caviezel C, Aruldas C, Franzen D, Ulrich S, Inci I, Schneiter D, Weder W, Opitz I. Lung volume reduction surgery in selected patients with emphysema and pulmonary hypertension. European Journal of Cardio-Thoracic Surgery. 2018;54(3):565-571.  https://doi.org/10.1093/ejcts/ezy092
  30. Pompeo E, Rogliani P, Cristino B, Fabbi E, Dauri M, Sergiacomi G. Staged unilateral lung volume reduction surgery: from mini-invasive to minimalist treatment strategies. Journal of Thoracic Disease. 2018;10(suppl 23):2754-2762. https://doi.org/10.21037/jtd.2018.05.171
  31. Zhu C, Chen Z, Chen B, Zhu H, Rice-Narusch W, Cai X, Shen J, Yang C. Thoracoscopic Treatment of Giant Pulmonary Bullae. Journal of Surgical Research. 2019;243:206-212.  https://doi.org/10.1016/j.jss.2019.05.009
  32. Roemers R, Patberg K, van de Wauwer C, Nguyen T, Shahin G. Robot-assisted thoracoscopic lobectomy as treatment of a giant bulla. Journal of Cardio-Thoracic Surgery. 2017;12(1):31.  https://doi.org/10.1186/s13019-017-0595-3
  33. Nikolaev GV, Varlamov VV, Iablonskiĭ PK, Chernyĭ SM, Kiriukhina LD, Sukhovskaia OA, Lukina OV, Akopov AL. Khirurgicheskaia reduktsiia ob»ema legkikh pri diffuznoĭ émfizeme. The surgical lung volume reduction in patients with diffuse emphysema. Bulletin of Surgery. I.I. Grekov. 2003;162(2):21-4. (In Russ.).
  34. Parshin VD, Dobrovolsky SR, Bazarov DV. Results of surgical reduction of lung volume in the treatment of patients with severe diffuse emphysema. Bulletin of the Peoples’ Friendship University of Russia. 2009;1:34-38. (In Russ.).
  35. Kostron A, Horn-Tutic M, Franzen D, Kestenholz P, Schneiter D, Opitz I, Kohler M, Weder W. Repeated lung volume reduction surgery is successful in selected patients. European Journal of Cardio-Thoracic Surgery. 2015;48(5):710-715.  https://doi.org/10.1093/ejcts/ezu498
  36. Gorbunkov SD, Varlamov VV, Cherny SM, Lukina OV, Akopov AL. Results of palliative surgical correction of respiratory failure depending on the type of emphysematous lesion. Bulletin of Surgery. I.I. Grekov. 2018;4(177):10-14. (In Russ.).
  37. Gorbunkov SD, Varlamov VV, Cherny SM, Lukina OV, Kiryukhina LD, Romanikhin AI, Zinchenko AV, Akopov AL. Palliativnaya khirurgicheskaya korrektsiya dykhatel’noy nedostatochnosti pri diffuznoy emfizeme legkikh. Khirurgiya. Zhurnal im. N.I. Pirogova. 2017;(10):52-56. (In Russ.). https://doi.org/10.17116/hirurgia20171052-56
  38. Ciccone AM, Meyers BF, Guthrie TJ, Davis GE, Yusen RD, Lefrak SS, Patterson GA, Cooper JD. Long-term outcome of bilateral lung volume reduction in 250 consecutive patients with emphysema. The Journal of Thoracic and Cardiovascular Surgery. 2003;125(3):513-25.  https://doi.org/10.1067/mtc.2003.147
  39. Tutic M, Bloch KE, Lardinois D, Brack T, Russi EW, Weder W. Long-term results after lung volume reduction surgery in patients with alpha1-antitrypsin deficiency. The Journal of Thoracic and Cardiovascular Surgery. 2004;128(3):408-413.  https://doi.org/10.1016/j.jtcvs.2004.03.040
  40. Thuppal S, Lanzotti N, Vost B, Crabtree T, Markwell S, Seadler B, Rizvi N, Sawyer J, McCullough K, Hazelrigg SR. Life Expectancy and Rate of Decline After Lung Volume Reduction Surgery. Thoracic Surgery Clinics. 2021;31(2):177-188.  https://doi.org/10.1016/j.thorsurg.2021.01.001
  41. Saha BK, Chong WH, Hu K, Saha S, Bonnier A, Chenna P. Pressure-dependent persistent air leak in a patient with secondary spontaneous pneumothorax. The American Journal of the Medical Sciences. 2022;364(6):782-788.  https://doi.org/10.1016/j.amjms.2022.06.013
  42. Cooper JD. Technique to reduce air leaks after resection of emphysematous lung. The Annals of Thoracic Surgery. 1994;57(4):1038-1039.
  43. Cooper JD, Patterson GA, Sundaresan RS, Trulock EP, Yusen RD, Pohl MS, Lefrak SS. Results of 150 consecutive bilateral lung volume reduction procedures in patients with severe emphysema. The Journal of Thoracic and Cardiovascular Surgery. 1996;112(5):1319-1329; discussion 1329-1330. https://doi.org/10.1016/S0022-5223(96)70147-2
  44. Moser C, Opitz I, Zhai W, Rousson V, Russi EW, Weder W, Lardinois D. Autologous fibrin sealant reduces the incidence of prolonged air leak and duration of chest tube drainage after lung volume reduction surgery: a prospective randomized blinded study. The Journal of Thoracic and Cardiovascular Surgery. 2008;136(4):843-849.  https://doi.org/10.1016/j.jtcvs.2008.02.079
  45. Milenkovic B, Janjic SD, Popevic S. Review of lung sealant technologies for lung volume reduction in pulmonary disease. Medical Devices. 2018;11:225-231.  https://doi.org/10.2147/MDER.S127136
  46. Romanikhin AI, Gorbunkov SD, Kovalev MG, Akopov AL. Influence of preoperative rehabilitation on the results of anatomic lung resections. Scientific notes of St. Petersburg State Medical University I.P. Pavlova. 2020;3(27):34-40. (In Russ.).
  47. Arjuna A, Olson MT, Walia R. Current trends in candidate selection, contraindications, and indications for lung transplantation. Journal of Thoracic Disease. 2021;13(11):6514-6527. https://doi.org/10.21037/jtd-2021-09
  48. Inci I. Lung transplantation for emphysema. Annals of Translation Medicine. 2020;8(21):1473. https://doi.org/10.21037/atm-20-805
  49. Slama A, Taube C, Kamler M, Aigner C. Lung volume reduction followed by lung transplantation-considerations on selection criteria and outcome. Journal of Thoracic Disease. 2018;10(suppl 27):3366-3375. https://doi.org/10.21037/jtd.2018.06.164
  50. Parshin VD, Rusakov MA, Bazarov DV, Kochneva ZV, Kulagina TYu, Khovrin VV, Filimonova MV. Endobronchial valve in the treatment of patients with end-stage pulmonary emphysema. Practical pulmonology. 2012;2:46-52. (In Russ.).
  51. Kesten S, Anderson JC, Tuck SA. Rationale for the development and the mechanism of action of endoscopic thermal vapor ablation (InterVapor) for the treatment of emphysema. Journal of Bronchology and Interventional Pulmonology. 2012;19(3):237-245.  https://doi.org/10.1097/LBR.0b013e31826137bc
  52. Poggi C, Mantovani S, Pecoraro Y, Carillo C, Bassi M, D’Andrilli A, Anile M, Rendina EA, Venuta F, Diso D. Bronchoscopic treatment of emphysema: an update. Journal of Thoracic Disease. 2018;10(11):6274-6284. https://doi.org/10.21037/jtd.2018.10.43
  53. Van Agteren JEM, Hnin K, Grosser D, Carson KV, Smith BJ. Bronchoscopic lung volume reduction procedures for chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews 2017;2(2):CD012158. https://doi.org/10.1002/14651858.CD012158.pub2
  54. Slebos DJ, Klooster K. Another STEP forward in emphysema treatment. The Lancet Respiratory Medicine. 2016;4(3):166-167.  https://doi.org/10.1016/S2213-2600(16)00062-X
  55. Koster TD, Dijk MV, Slebos DJ. Bronchoscopic Lung Volume Reduction for Emphysema: Review and Update. Seminars in Respiratory and Critical Care Medicine. 2022;43(4):541-551.  https://doi.org/10.1055/s-0042-1747938
  56. Hartman JE, Vanfleteren LEGW, van Rikxoort EM, Klooster K, Slebos DJ. Endobronchial valves for severe emphysema. The European Respiratory Review. 2019;28(152):180121. https://doi.org/10.1183/16000617.0121-2018
  57. Davey C, Zoumot Z, Jordan S, McNulty WH, Carr DH, Hind MD, Hansell DM, Rubens MB, Banya W, Polkey MI, Shah PL, Hopkinson NS. Bronchoscopic lung volume reduction with endobronchial valves for patients with heterogeneous emphysema and intact interlobar fissures (the BeLieVeR-HIFi study): a randomised controlled trial. Lancet. 2015;386(9998):1066-1073. https://doi.org/10.1016/S0140-6736(15)60001-0
  58. Perotin JM, Leroy S, Marquette CH, Mal H, Dutau H, Bourdin A, Vergnon JM, Pison C, Barbe C, Deslee G; REVOLENS Study Group. Endobronchial coil treatment in severe emphysema patients with alpha-1 antitrypsin deficiency. International Journal of Chronic Obstructive Pulmonary Disease. 2018;13:3645-3649. https://doi.org/10.2147/COPD.S176366
  59. Shah PL, Slebos DJ, Cardoso PF, Cetti E, Voelker K, Levine B, Russell ME, Goldin J, Brown M, Cooper JD, Sybrecht GW; EASE trial study group. Bronchoscopic lung-volume reduction with Exhale airway stents for emphysema (EASE trial): randomised, sham-controlled, multicentre trial. Lancet. 2011;378(9795):997-1005. https://doi.org/10.1016/S0140-6736(11)61050-7
  60. Franzen D, Straub G, Freitag L. Complications after bronchoscopic lung volume reduction. Journal of Thoracic Disease. 2018;10(suppl 23):2811-2815. https://doi.org/10.21037/jtd.2018.06.66

Close metadata

Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.